Treatment satisfaction, disease severity, and health-care use in patients with axial spondyloarthritis in the United States and Europe

Read full text Summarise with VIRAT
Authors: Elena Nikiphorou, Alexis Ogdie, Dan Twigg, Emily Quiñones, You‐Li Ling, Joseph C. Cappelleri, Lídia Sànchez-Riera, Karim Richard Masri, Megan Hughes1, Nicola Massey
Cited by: 0
References: 34

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVES: The heterogeneous presentation of axial SpA (axSpA) complicates diagnosis and treatment decisions. This study compared patient symptoms, health-care resource utilization, and physician-patient alignment on disease severity and treatment satisfaction between the USA and five European countries (5EU). METHODS: Data were drawn from the Adelphi axSpA Disease Specific Programme (DSP)™, a real-world cross-sectional survey conducted in the USA and 5EU between March and November 2021. Rheumatologists reported on consecutive patients, including clinical characteristics, disease severity, symptomatic burden, treatment history, health-care resource utilization, and treatment satisfaction. Patients reported on disease severity, treatment satisfaction, and other validated patient-reported outcome measures. Physician-patient alignment was quantified using weighted kappa analyses. RESULTS: A total of 349 rheumatologists provided data for 2750 patients (USA = 656, 5EU = 2094), of whom 1011 (36.8%) self-reported data. The mean (s.d.) numbers of symptoms at diagnosis were similar [USA: 6.0 (4.4) vs 5EU: 6.4 (4.3); P = 0.0657]; however, the mean [s.d.] numbers of symptoms at data collection was greater in the USA than in 5EU [3.3 (3.3) vs 2.3 (2.8), respectively; P < 0.0001]. Physician-patient alignment on disease severity at diagnosis (κ = 0.37 vs κ = 0.47), treatment initiation (κ = 0.32 vs κ = 0.42) and data collection (κ = 0.32 vs κ = 0.61), and treatment satisfaction (κ = 0.35 vs κ = 0.42) were lower in the USA than in 5EU. The mean [s.d.] number of consultations in the previous 12 months was lower in the USA than in 5EU [5.2 (3.4) vs 6.5 (5.1); P = 0.0008], although mean hospitalizations were similar. CONCLUSION: Differences in symptomatic burden and care were observed between regions. Identifying care gaps will aid in implementing targeted improvements in treatment, minimizing the risk of health inequalities.

Fields of Study & Subjects

Spondyloarthritis Studies and Treatments Musculoskeletal pain and rehabilitation Scoliosis diagnosis and treatment

Publication details

Journal / source
Rheumatology
Volume
65
Issue
3
Publication date
1 March 2026
Language
EN